Intco Medical Technology Co., Ltd. (SHE:300677)
China flag China · Delayed Price · Currency is CNY
39.35
-0.73 (-1.82%)
At close: Feb 13, 2026

Intco Medical Technology Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
9,69812,0147,2225,0335,0035,009
Short-Term Investments
--723.211,613--
Trading Asset Securities
12,6396,7375,2361,6243,2741,381
Cash & Short-Term Investments
22,33718,75113,1818,2708,2776,390
Cash Growth
21.50%42.26%59.39%-0.09%29.52%632.70%
Accounts Receivable
1,4161,379937.18555.36775.15516.88
Other Receivables
106.1978.3341.8980.9330.664.14
Receivables
1,5221,457979.08636.29805.75581.03
Inventory
1,2841,2651,1501,0041,079847.45
Other Current Assets
478.66480.62292.93325.23600.95690.81
Total Current Assets
25,62221,95515,60310,23510,7638,510
Property, Plant & Equipment
11,3609,7909,2468,9118,2623,572
Long-Term Investments
1,5711,382970.38884.94473.8915.67
Other Intangible Assets
732.72767.03566.84583.48629.91349.48
Long-Term Deferred Tax Assets
54.5780.3564.0988.3177.23158.77
Long-Term Deferred Charges
4.995.221.841.762.914.91
Other Long-Term Assets
619.84651.63627.32774.31415.84314.2
Total Assets
39,96634,63127,07921,47920,62512,935
Accounts Payable
1,018845.38921.6946.361,238856.09
Accrued Expenses
117.1199.83174.47201.53194124.49
Short-Term Debt
16,70312,6667,0341,49450.4822.18
Current Portion of Long-Term Debt
558.93436.3753.429.0434.2927.88
Current Portion of Leases
--1.944.012.64-
Current Income Taxes Payable
91.1965.1815.649.6337.5163.26
Current Unearned Revenue
283.94271.58293.6300.89414.16917.4
Other Current Liabilities
303.58197.97123.67169.43113.07116.79
Total Current Liabilities
19,07614,6838,6183,1552,0842,228
Long-Term Debt
545.32166.877.2551.59201.26230.09
Long-Term Leases
---1.783.38-
Long-Term Unearned Revenue
193.31155.84123.99128.53201.0268.14
Long-Term Deferred Tax Liabilities
1,6831,9441,9652,0932,012965.72
Total Liabilities
21,49816,94910,7855,4294,5013,492
Common Stock
654.79646.19656659.55549.58352.22
Additional Paid-In Capital
1,1721,1141,2871,3101,5091,586
Retained Earnings
16,60615,77814,39614,07213,8557,481
Treasury Stock
-251.65-133.47-320.55-253.81-27.76-72.21
Comprehensive Income & Other
-20.62-0.3810.6318.79-15.22-2.45
Total Common Equity
18,16017,40416,02915,80615,8719,344
Minority Interest
307.37277.6265.99242.93252.2598.91
Shareholders' Equity
18,46717,68216,29516,04916,1239,443
Total Liabilities & Equity
39,96634,63127,07921,47920,62512,935
Total Debt
17,80813,2697,1661,580292.05280.15
Net Cash (Debt)
4,5295,4826,0156,6897,9856,110
Net Cash Growth
-11.44%-8.86%-10.08%-16.23%30.68%-
Net Cash Per Share
7.138.459.1110.1011.829.86
Filing Date Shares Outstanding
643.93641.39643.38659.55659.49634
Total Common Shares Outstanding
643.93641.39643.38659.55659.49634
Working Capital
6,5467,2726,9857,0808,6796,282
Book Value Per Share
28.2027.1424.9123.9724.0714.74
Tangible Book Value
17,42716,63715,46215,22315,2418,994
Tangible Book Value Per Share
27.0625.9424.0323.0823.1114.19
Land
-11.7211.7211.5210.55-
Buildings
-4,5574,0573,4802,400883.6
Machinery
-6,6245,6134,9864,2472,305
Construction In Progress
-1,2881,5091,7052,326863.41
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.